10412733

Source:http://linkedlifedata.com/resource/pubmed/id/10412733

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011881, umls-concept:C0020473, umls-concept:C0022658, umls-concept:C0035820, umls-concept:C0205234, umls-concept:C0205329
pubmed:dateCreated	1999-9-15
pubmed:abstractText	It has been suggested that lipids promote renal injury and that 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors confer renoprotection in certain renal diseases, including diabetic nephropathy.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7508622
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Lovastatin, http://linkedlifedata.com/resource/pubmed/chemical/Pravastatin, http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta, http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0098-6577
pubmed:author	pubmed-author:CaoZZ, pubmed-author:CooperM EME, pubmed-author:CoxA JAJ, pubmed-author:GilbertR ERE, pubmed-author:Jandeleit-DahmKK, pubmed-author:KellyD JDJ
pubmed:issnType	Print
pubmed:volume	71
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	S31-6
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:10412733-Animals, pubmed-meshheading:10412733-Anticholesteremic Agents, pubmed-meshheading:10412733-Clinical Trials as Topic, pubmed-meshheading:10412733-Diabetic Nephropathies, pubmed-meshheading:10412733-Disease Progression, pubmed-meshheading:10412733-Gene Expression, pubmed-meshheading:10412733-Heptanoic Acids, pubmed-meshheading:10412733-Humans, pubmed-meshheading:10412733-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:10412733-Hyperlipidemias, pubmed-meshheading:10412733-In Situ Hybridization, pubmed-meshheading:10412733-Kidney Diseases, pubmed-meshheading:10412733-Kidney Glomerulus, pubmed-meshheading:10412733-Lovastatin, pubmed-meshheading:10412733-Male, pubmed-meshheading:10412733-Nephrectomy, pubmed-meshheading:10412733-Pravastatin, pubmed-meshheading:10412733-Pyrroles, pubmed-meshheading:10412733-Rats, pubmed-meshheading:10412733-Rats, Sprague-Dawley, pubmed-meshheading:10412733-Simvastatin, pubmed-meshheading:10412733-Transforming Growth Factor beta
pubmed:year	1999
pubmed:articleTitle	Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy.
pubmed:affiliation	Department of Medicine, University of Melbourne, Austin, Victoria, Australia.
pubmed:publicationType	Journal Article, Review, Research Support, Non-U.S. Gov't